Testing a Screener for Muscle Stiffness After Stroke
Tests a spasticity screener to see whether it helps clinicians in adults after stroke.
Plain-language title generated from the registry record
Registry title: Reduce Inefficiencies in Management of Spasticity
Key facts
- Where
- Houston, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT07639632, who can take part
Where in United States
- The University of Texas Health Science Center at Houston PO Box 20036Houston, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Texas Health Science Center, Houston
- Trial code
- NCT07639632
- Record updated
- 12 June 2026
- Original description
The purpose of this study is to evaluate the effectiveness of a spasticity screener and to determine if the spasticity screener results are useful to healthcare providers and impact clinical decision makingRead full original descriptionShow less
Reduce Inefficiencies in Management of Spasticity
The purpose of this study is to evaluate the effectiveness of a spasticity screener and to determine if the spasticity screener results are useful to healthcare providers and impact clinical decision making
Inclusion: Currently admitted for an acute hemorrhagic or ischemic stroke; recurrent stroke allowed if no spasticity at baseline; NIHSS score of > 0 on items 5 or 6 (required of at least 1 limb); Willingness to participate in the study for 24 months; Able to sign consent form or availability of a legally authorized representative to sign; Able to read/write in English; Identified MD for follow up post hospitalization.
Exclusion: Prior limb injury or neurological diagnosis that limited movement in the now affected limb(s); Acute life threatening illness; Any terminal illness that would limit participation in study follow ups; Known spasticity or other movement disorders that impact tone; Botulinum toxin use for any indication within the past 12 weeks.